|
COX15 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
1.202830E-03 |
| Normal-vs-Stage3 |
1.99840144432528E-15 |
| Normal-vs-Stage4 |
1.63824509513688E-12 |
| Stage1-vs-Stage2 |
2.824300E-03 |
| Stage1-vs-Stage3 |
1.086610E-01 |
| Stage1-vs-Stage4 |
2.025600E-02 |
| Stage2-vs-Stage3 |
9.88170000000288E-05 |
| Stage2-vs-Stage4 |
4.23499999999688E-05 |
| Stage3-vs-Stage4 |
3.567400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
1.48609999994775E-06 |
| Normal-vs-Asian |
1.40309985852127E-10 |
| Caucasian-vs-AfricanAmerican |
4.107200E-01 |
| Caucasian-vs-Asian |
6.070800E-01 |
| AfricanAmerican-vs-Asian |
6.880200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.38777878078145E-14 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
3.900400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(41-60Yrs) |
3.99680288865056E-15 |
| Normal-vs-Age(61-80Yrs) |
1.64619995413062E-09 |
| Normal-vs-Age(81-100Yrs) |
1.402020E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.843400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.276240E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.370400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.406370E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.974600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.042400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.039400E-04 |
| Classical-VS-Follicular |
1.52938999999908E-05 |
| Classical-VS-Other |
6.658000E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
1.1205000260972E-09 |
| Tall-VS-Other |
4.032000E-01 |
| Tall-VS-Normal |
1.11022302462516E-16 |
| Follicular-VS-Other |
8.133500E-02 |
| Follicular-VS-Normal |
1.010630E-04 |
| Other-VS-Normal |
4.826300E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.22168982999938E-13 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
2.62929999994554E-06 |
|
|
